Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Biochem ; 257(1): 121-30, 1998 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-9799110

RESUMEN

The topology of the binding site has been studied for two monoclonal antibodies 13G10 and 14H7, elicited against iron(III)-alpha,alpha,alpha,beta-meso-tetrakis(ortho-carboxyphenyl)porph yrin [alpha,alpha,alpha, beta-Fe[(o-COOHPh)4-porphyrin]], and which exhibit in the presence of this alpha,alpha,alpha, beta-Fe[(o-COOHPh)4-porphyrin] cofactor a peroxidase activity. A comparison of the dissociation constants of the complexes of 13G10 and 14H7 with various tetra-aryl-substituted porphyrin has shown that: (a) the central iron(III) atom of alpha,alpha,alpha,beta-Fe[(o-COOHPh)4-porphyrin] is not recognized by either of the two antibodies; and (b) the ortho-carboxylate substituents of the meso-phenyl rings of alpha,alpha,alpha, beta-Fe[(o-COOHPh)4-porphyrin] are essential for the recognition of the porphyrin by 13G10 and 14H7. Measurement of the dissociation constants for the complexes of 13G10 and 14H7 with the four atropoisomers of (o-COOHPh)4-porphyrinH2 as well as mono- and di-ortho-carboxyphenyl-substituted porphyrins suggests that the three carboxylates in the alpha, alpha, beta position are recognized by both 13G10 and 14H7 with the two in the alpha, beta positions more strongly bound to the antibody protein. Accordingly, the topology of the active site of 13G10 and 14H7 has roughly two-thirds of the alpha,alpha,alpha,beta-Fe[(o-COOHPh)4-porphyrin] cofactor inserted into the binding site of the antibodies, with one of the aryl ring remaining outside. Three of the carboxylates are bound to the protein but no amino acid residue acts as an axial ligand to the iron atom. Chemical modification of lysine, histidine, tryptophan and arginine residues has shown that only modification of arginine residues causes a decrease in both the binding of alpha,alpha,alpha, beta-Fe[(o-COOHPh)4-porphyrin] and the peroxidase activity of both antibodies. Consequently, at least one of the carboxylates of the hapten is bound to an arginine residue and no amino acids such as lysine, histidine or tryptophan participate in the catalysis of the heterolytic cleavage of the O-O bond of H2O2. In addition, the amino acid sequence of both antibodies not only reveals the presence of arginine residues, which could be those involved in the binding of the carboxylates of the hapten, but also the presence of several amino acids in the complementary determining regions which could bind other carboxylates through a network of H bonds.


Asunto(s)
Anticuerpos Monoclonales/química , Hemoproteínas/química , Peroxidasas/química , Porfirinas/química , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/genética , Anticuerpos Monoclonales/inmunología , Secuencia de Bases , Sitios de Unión , Cartilla de ADN , Femenino , Hemoproteínas/inmunología , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Estructura Molecular , Homología de Secuencia de Aminoácido
2.
Biochemistry ; 30(37): 8964-70, 1991 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-1654081

RESUMEN

Inhibition of soybean lipoxygenase (L-1) and potato 5-lipoxygenase (5-PLO) by the pyrazoline derivatives phenidone and BW755C only occurs after oxidation of these compounds by the peroxidase-like activity of the lipoxygenases. There is a clear relationship between this oxidation and the irreversible inactivation of L-1. The final product of phenidone oxidation by L-1, 4,5-didehydrophenidone, is not responsible of this inactivation, but the species derived from a one-electron oxidation of phenidone plays a key role in L-1 inactivation. In the absence of O2, inactivation of 1 mol of L-1 occurs after the oxidation of 34 mol of phenidone and the covalent binding of 0.8 mol of phenidone-derived metabolite(s) to L-1. In the presence of O2, inactivation of 1 mol of L-1 occurs already after oxidation of 11 mol of phenidone and only involves the covalent binding of 0.4 mol of phenidone-derived metabolite(s) to L-1. A mechanism is proposed for L-1 inactivation by phenidone, which involves the irreversible binding of a phenidone metabolite to the protein and the oxidation of an L-1 amino acid residue (in the presence of O2).


Asunto(s)
4,5-dihidro-1-(3-(trifluorometil)fenil)-1H-pirazol-3-amina/farmacología , Inhibidores de la Lipooxigenasa , Pirazoles/farmacología , Sal Disódica del Ácido 1,2-Dihidroxibenceno-3,5-Disulfónico/farmacología , Araquidonato 5-Lipooxigenasa/sangre , Ácido Ascórbico/farmacología , Catalasa/farmacología , Espectroscopía de Resonancia por Spin del Electrón , Activación Enzimática/efectos de los fármacos , Compuestos Férricos/química , Humanos , Leucocitos/efectos de los fármacos , Leucocitos/enzimología , Lipooxigenasa/química , Oxidación-Reducción , Oxígeno/fisiología , Solanum tuberosum/enzimología , Glycine max/enzimología , Compuestos de Sulfhidrilo/farmacología , Superóxido Dismutasa/farmacología
3.
Biochim Biophys Acta ; 1081(1): 99-105, 1991 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-1846759

RESUMEN

Potato 5-lipoxygenase (5-PLO) catalyzes the reduction of 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (13-HPOD) in the presence of vitamin E. I mol of vitamin E is required to consume 2 mol of 13-HPOD. The mechanism of the 5-PLO-catalyzed oxidation of vitamin E by 13-HPOD is similar to that previously established for the soybean 15-lipoxygenase (L-1)-catalyzed oxidation of phenidone by 13-HPOD, and seems to involve a one-electron reduction of the O-O bond of 13-HPOD. 5-PLO and L-1 exhibit very different substrate specificities and pH profiles for their peroxidase-like activity. Actually, among the 20 compounds containing various reducible functions and the 10 derivatives of vitamin E which have been studied, only four products containing hydrophobic long chains, ascorbic acid 6-palmitate, the trolox esters of octanol and undecanol, and vitamin E exhibit high peroxidase-like activities for 5-PLO. On the contrary, much more compounds, even not very hydrophobic, are good substrates for the peroxidase-like activity of L-1.


Asunto(s)
Araquidonato 15-Lipooxigenasa/metabolismo , Araquidonato 5-Lipooxigenasa/metabolismo , Glycine max/enzimología , Peroxidasas , Solanum tuberosum/enzimología , Vitamina E/análogos & derivados , Vitamina E/metabolismo , Cromatografía Líquida de Alta Presión , Espectroscopía de Resonancia por Spin del Electrón , Cinética , Oxidación-Reducción , Especificidad por Sustrato
4.
Biochem J ; 241(2): 561-5, 1987 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-3036068

RESUMEN

Lipid peroxidation in rat liver microsomes induced by asbestos fibres, crocidolite and chrysotile, is greatly increased in the presence of NADPH, leading to malondialdehyde levels comparable with those induced by CCl4, a very strong inducer of lipid peroxidation. This synergic effect only occurs during the first minutes and could be explained by an increase or a regeneration of the ferrous active sites of asbestos by NADPH, which in turn could rapidly be prevented by the adsorption of microsomal proteins on the surface of the fibres. It is not inhibited by superoxide dismutase, catalase and mannitol, indicating that oxygen radicals are not involved in the reaction. It is also not inhibited by desferrioxamine, indicating that it is not due to a release of free iron ions in solution from the fibres. Lipid peroxidation in NADPH-supplemented microsomes is also greatly increased upon addition of magnetite. This could be linked to the presence of ferrous ions in this solid iron oxide, since the ferric oxides haematite and goethite are completely inactive.


Asunto(s)
Amianto/farmacología , Peróxidos Lipídicos/metabolismo , Microsomas Hepáticos/metabolismo , NADP/farmacología , Animales , Asbesto Crocidolita , Asbestos Serpentinas , Sinergismo Farmacológico , Hierro/farmacología , Masculino , Microsomas Hepáticos/efectos de los fármacos , Oxidación-Reducción , Ratas , Ratas Endogámicas
5.
Chem Biol Interact ; 25(2-3): 279-87, 1979 May.
Artículo en Inglés | MEDLINE | ID: mdl-380828

RESUMEN

9-Hydroxyellipticine (9-OHE), an inhibitor of microsomal monooxygenase activities has been shown to exert a large or even complete decrease of the mutagenicity, on the Salmonella strains of a great number of compounds (aromatic amines, polycyclic aromatic hydrocarbons, fungal toxins, azo compounds, tobacco smoke condensate). 9-OHE and 9-fluoroellipticine are more potent inhibitors than ellipticine itself. The inhibitions exerted by 9-OHE are not even equalled by 10-fold higher doses of 7,8-benzoflavone (7,8-BF). There is a good correlation between these data and the interaction properties of ellipticines with microsomal cytochromes P-450.


Asunto(s)
Alcaloides/farmacología , Elipticinas/farmacología , Microsomas Hepáticos/metabolismo , Mutágenos , Mutación/efectos de los fármacos , Animales , Evaluación Preclínica de Medicamentos , Masculino , Ratas , Salmonella typhimurium/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA